• Black Facebook Icon
  • Black Twitter Icon
  • Black LinkedIn Icon

Copyright 2019 Medical Technology Partners

Medical Reimbursement Consultant I  Rockville, MD I Medical Technology Partners

News

 

The Centers for Medicare and Medicaid Services (CMS) announced significant improvements in managing the Medicaid program in partnership with states.  Identified early as a priority for both the Trump Administration and the National Association of Medicaid Director’s (NAMD), CMS has implemented changes resulting in faster processing of state requests to make program or benefit changes to their Medicaid program through the state plan amendment (SPA) and section 1915 waiver review process.  

 

Medical Technology Partners, announced that Nancy Young, its long-term senior officer, has acquired the Medical Association of Billers.

 

The Centers for Medicare & Medicaid Services (CMS) finalized a rule to empower patients and advance the White House MyHealthEData initiative and the CMS Patients Over Paperwork initiative. This final rule and others issued earlier this week will help improve access to hospital price information, give patients greater access to their health information and allow clinicians to spend more time with their patients.

The Centers for Medicare and Medicaid Services (CMS) has introduced new information on qpp.cms.gov that indicates whether clinicians have “special status” and can, therefore, be considered exempt from the Quality Payment Program.

 

 

The departments of Health and Human Services, Labor and the Treasury issued a final rule to help Americans struggling to afford health coverage find new, more affordable options. The rule allows for the sale and renewal of short-term, limited-duration plans that cover longer periods than the previous maximum period of less than three months. Such coverage can now cover an initial period of less than 12 months, and, taking into account any extensions, a maximum duration of no longer than 36 months in total. This action will help increase choices for Americans faced with escalating premiums and dwindling options in the individual insurance market. 

 

 

The Centers for Medicare and Medicaid Services (CMS) released a letter to State Medicaid Directors that clearly describes CMS’s current approach to calculating budget neutrality expenditure limits for Medicaid section 1115 demonstration projects. Medicaid demonstration projects allow states to design innovative ways to better serve the nation’s more than 65 million Medicaid recipients. In response to longstanding concerns raised by the Government Accountability Office (GAO), this letter marks the first time that CMS has formally outlined how states must calculate budget neutrality for demonstration projects, in order to strengthen fiscal accountability.

 

 

 

 

 

MTP congratulates its client, Augmenix, on its sale to Boston Scientific

 

Augmenix developed, manufactures and sells a transperineal spacer (“SpaceOar”) that has been demonstrated, in randomized clinical trials, to improve the outcomes of radiation treatment of prostate cancer.   The sale, which includes $500 million cash upfront, is a great tribute to John Pedersen and his team.  Special kudos to Mike Mydra, Vice President for executing a well-thought reimbursement plan and to the Company’s clinical team to investing in and executing studies that conclusively demonstrated the clinical benefits of SpaceOar for prostate cancer patients. 

 

Augmenix represents the fourth MTP client to sell in the past 12 months for at least $500 million. 

 

The Centers for Medicare and Medicaid Services (CMS) announced significant improvements in managing the Medicaid program in partnership with states.  Identified early as a priority for both the Trump Administration and the National Association of Medicaid Director’s (NAMD), CMS has implemented changes resulting in faster processing of state requests to make program or benefit changes to their Medicaid program through the state plan amendment (SPA) and section 1915 waiver review process.  

MTP is pleased that its long-term client, SI-BONE, released its S1 registration to go public.   This represents its second client to go public this year, joining four other clients that have exited via acquisition. 

Medical Technology Partners 

Reimbursement-Driven Commercialization Services

Strategy  |  Tactics  |  Implementation